The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1699-3055
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer ; day:6 ; month:10 ; year:2022 ; pages:1-12
Clinical and translational oncology ; (6.10.2022), 1-12
- Urheber
-
Li, Liuxun
Xu, Jiangli
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12094-022-02957-x
- URN
-
urn:nbn:de:101:1-2022122509101633678048
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Liuxun
- Xu, Jiangli
- SpringerLink (Online service)
Ähnliche Objekte (12)
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Androgen deprivation modulates the inflammatory response induced by irradiation
Androgen regulation of the androgen receptor coregulators
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Androgen deprivation modulates the inflammatory response induced by irradiation
Androgen regulation of the androgen receptor coregulators
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Androgen deprivation modulates the inflammatory response induced by irradiation
Androgen regulation of the androgen receptor coregulators
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer